Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-a-NET in NETs